Company intelligence / Profile preview

AlgoSource

Saint-Nazaire, Pays de la Loire, Francealgosource.com ↗
Ownership
Private
Employees
~37
Development stage
Commercial
01

Overview

AlgoSource has demonstrated the effectiveness of its spirulina liquid extract in a clinical trial targeting NASH syndrome. The company is also developing AmiTher, a microalgae-based solution to reduce side effects of cancer therapies, with planned hospital-based clinical trials. Products are subject to internal/external quality controls before market release.

Therapeutic areas
OncologyGastroenterology
Modalities
Microalgae-derived functional ingredientsNatural extracts
Industry
Biotech
02

Drug pipeline

2 assets

Spirulysat

Preclinical

1 more asset in the full pipeline.

Request access →
03

Partnerships

University of Nantes & Center for Human Nutrition Research “Ouest” (clinical research collaboration)Alpha Biotech (industrial production partnership/historical link)Pôle Mer Bretagne Atlantique cluster ("AmiTher" labeled by this cluster)

Beyond the preview

Go deeper on AlgoSource.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AlgoSource.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call